Anticoagulant
Anticoagulation for Atrial Fibrillation Post-Ablation
Recruiting3 awardsPhase 4
Calgary, Alberta
This trial is comparing medical approaches for stroke prevention in people who have atrial fibrillation (AF) and have undergone a successful procedure called ablation to eliminate or substantially reduce the arrhythmia.
Anticoagulant
Rivaroxaban + Aspirin for Peripheral Artery Disease
Recruiting2 awardsPhase 4
Nashville, Tennessee
This trial is testing a drug that prevents blood clots in patients with poor blood flow in their arteries. The drug works by blocking a protein that helps blood to clot, which may improve their symptoms. When combined with aspirin, it has shown significant benefits in reducing deaths and heart-related problems in these patients.
Popular Filters
Phase 3 Trials
Anticoagulant
Rivaroxaban + Aspirin for Blood Clot Prevention After Joint Surgery
Recruiting4 awardsPhase 3
Halifax, Nova Scotia
This trial will test whether adding rivaroxaban to aspirin helps prevent venous thromboembolism better than aspirin alone in patients undergoing hip or knee replacement surgery.
Blood Thinner for Radial Artery Occlusion
Recruiting2 awardsPhase 3
Ottawa, Ontario
This trial is testing if taking a pill after a coronary procedure can prevent artery blockage. It focuses on patients who have the procedure done through their wrist artery. The goal is to see if this pill can help keep the artery open for future use.
Anticoagulant
Rivaroxaban + Ticagrelor for Atrial Fibrillation After Stent Placement
Recruiting2 awardsPhase 3
Ottawa, Ontario
This trial is testing a new combination of two drugs, ticagrelor and rivaroxaban, for patients with atrial fibrillation who have had heart artery procedures. The goal is to see if this combination can reduce the risk of heart attacks and strokes with fewer bleeding complications compared to current treatments.
Trials With No Placebo
Anticoagulant
Rivaroxaban + Aspirin for Blood Clot Prevention After Joint Surgery
Recruiting4 awardsPhase 3
Halifax, Nova Scotia
This trial will test whether adding rivaroxaban to aspirin helps prevent venous thromboembolism better than aspirin alone in patients undergoing hip or knee replacement surgery.
Anticoagulant
Blood Thinners for Atrial Fibrillation
Recruiting3 awardsPhase 4
Edmonton, Alberta
This trial is testing whether taking blood-thinning pills can prevent strokes and other heart issues in patients who have temporary irregular heartbeats and are at risk of stroke after surgery. These pills are a recent breakthrough in preventing strokes.
Blood Thinner for Radial Artery Occlusion
Recruiting2 awardsPhase 3
Ottawa, Ontario
This trial is testing if taking a pill after a coronary procedure can prevent artery blockage. It focuses on patients who have the procedure done through their wrist artery. The goal is to see if this pill can help keep the artery open for future use.
Anticoagulant
Anticoagulants vs Antiplatelets for Blood Clot Prevention After Heart Procedure
Recruiting3 awardsPhase 4
Quebec
This trial compares two ways to prevent blood clots around a device used to treat heart problems. One is a short course of a blood thinner called a DOAC. The other is a daily antiplatelet pill.
Anticoagulant
Rivaroxaban + Ticagrelor for Atrial Fibrillation After Stent Placement
Recruiting2 awardsPhase 3
Ottawa, Ontario
This trial is testing a new combination of two drugs, ticagrelor and rivaroxaban, for patients with atrial fibrillation who have had heart artery procedures. The goal is to see if this combination can reduce the risk of heart attacks and strokes with fewer bleeding complications compared to current treatments.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.